- Home
- GOVX vs GVH Comparison
GOVX vs GVH Comparison
Compare GOVX & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOVX | GVH |
|---|---|---|
| Founded | 2001 | 2016 |
| Country | United States | Australia |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 6.8M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | GOVX | GVH |
|---|---|---|
| Price | $0.22 | $1.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.00 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 4.1M | 1.1M |
| Earning Date | 11-13-2025 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 11.95 |
| Revenue | $3,353,560.00 | ★ $21,878,867.00 |
| Revenue This Year | N/A | $141,706.20 |
| Revenue Next Year | N/A | $3.35 |
| P/E Ratio | ★ N/A | $0.11 |
| Revenue Growth | 8.52 | ★ 24.52 |
| 52 Week Low | $0.12 | $1.28 |
| 52 Week High | $2.71 | $364.00 |
Technical Indicators
Market Signals| Indicator | GOVX | GVH |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 29.17 |
| Support Level | $0.16 | $1.28 |
| Resistance Level | $0.21 | $4.90 |
| Average True Range (ATR) | 0.04 | 0.52 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 46.55 | 2.21 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.